Karyopharm Therapeutics Inc
KPTI
NASDAQ
Biotechnology
$2.02
USD
+0.03 (+1.51%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $45.10M
Volume 872.2K
Price Target
$3.00 – $3.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $3.00 and a min estimate of $3.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$3.00
-$15.0 vs prior
Implied Upside
+48.5%
-742.6% vs prior
Analyst Covering
1
-3 vs prior period
Consensus
Hold
Declined vs prior
Signal Quality
Consensus Freshness
20%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Hold
0 Buy
1 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Robert Burns | HC Wainwright & Co. | Hold | Downgraded | 2 weeks ago | Plus | Plus | Plus |
Frequently Asked Questions
